Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;171(1):85-98.
doi: 10.1093/rpd/ncw226. Epub 2016 Sep 2.

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES BIODOSIMETRY AND RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE PROGRAMS

Mary J Homer  1 , Robert Raulli  2 , Andrea L DiCarlo-Cohen  3 , John Esker  2 , Chad Hrdina  4 , Bert W Maidment  3 , Brian Moyer  2 , Carmen Rios  3 , Francesca Macchiarini  3 , Pataje G Prasanna  5 , Lynne Wathen  2
Affiliations

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES BIODOSIMETRY AND RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE PROGRAMS

Mary J Homer et al. Radiat Prot Dosimetry. 2016 Sep.

Abstract

The United States Department of Health and Human Services (HHS) is fully committed to the development of medical countermeasures to address national security threats from chemical, biological, radiological, and nuclear agents. Through the Public Health Emergency Medical Countermeasures Enterprise, HHS has launched and managed a multi-agency, comprehensive effort to develop and operationalize medical countermeasures. Within HHS, development of medical countermeasures includes the National Institutes of Health (NIH), (led by the National Institute of Allergy and Infectious Diseases), the Office of the Assistant Secretary of Preparedness and Response/Biomedical Advanced Research and Development Authority (BARDA); with the Division of Medical Countermeasure Strategy and Requirements, the Centers for Disease Control and Prevention, and the Food and Drug Administration as primary partners in this endeavor. This paper describes various programs and coordinating efforts of BARDA and NIH for the development of medical countermeasures for radiological and nuclear threats.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PHEMCE mission components and partners(2).
Figure 2.
Figure 2.
Diagram of the Radiation TRiage, TReatment, TRansport System(3, 5).
Figure 3.
Figure 3.
MCMs and the spectrum of care.
Figure 4.
Figure 4.
BARDA organization: core services.
See this image and copyright information in PMC

References

    1. Enterprise UPHEMC. Public Health Emeregency Medical Countermeasures Enterprise (PHEMCE) Strategy. In: Services UDoHaH (2012).
    1. Enterprise UPHEMC. Public Health Emeregency Medical Countermeasures Enterprise (PHEMCE) Implementation Plan In: Services UDoHaH (2012).
    1. Project Bioshield Act of 2004, 6A USC, §201 (2004).
    1. Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible (“Animal Rule”). 21 C.F.R. §314.600 (revised 2014). - PubMed
    1. Approval of Biological Products When Human Efficacy Studies Are Not Ethical or Feasible (“Animal Rule”). 21 C.F.R. §601.90 (revised 2014).